“Incremental Risk of Adverse Events with Oral Janus Kinase Inhibitor Use in Atopic Dermatitis and Other Indications: A Systematic Review and Meta-Analysis”, J of Skin, vol. 8, no. 1, p. s320, Jan. 2024, doi: 10.25251/skin.8.supp.320.